Kidney diseases are a global health challenge, affecting 10-20% of the population and significantly impacting quality of life. Therefore, our new research article in the SIC project focuses on the use of peptide bioregulators (such as Pielotax, Ovagen, and Renefort) in the prevention and treatment of kidney pathologies.
Mamiton from Peptides was developed by experts to support the female body and reduce the risk of cancer.
Subscribe to mailing and get the latest news and discounts of our store.>
A new era of growth and success: Peptides celebrates 6 years in Europe!
It has been six years since we opened our European representative office. We are proud to celebrate this important milestone, which is the result of the diligence and dedication of our partners.
Over the years, Peptides’ team of like-minded people has grown significantly, and our product range has expanded across Europe and beyond. We have scaled our network of dealerships, and we have also focused on building strong, friendly relationships within our team — people are the core value of Peptides. It is pleasing to see that an increasing number of partners from across the globe, including Europe, Latin America, USA, Asia and Australia, are coming on board with Peptides, which indicates a growing alignment with the company’s ideas and values.
Dear Colleagues and Friends, we would like to express our gratitude for your competence, creativity and commitment to excellence. We have a challenging journey ahead, and we look forward to embarking on it with you. We are confident that together we will achieve even greater success and realize our most ambitious plans.
«We believe in the unity of health and beauty, which helps to create a better life! »
Head of the Peptides team in Europe,
Viacheslav Vasilenko
*We kindly invite you to enjoy a festive discount of −10% on all products in all European dealerships from 4 to 8 November inclusively!
Make the most of this opportunity to treat yourself and your loved ones to with healthy and enjoyable purchases!
Kidney diseases are a global health challenge, affecting 10-20% of the population and significantly impacting quality of life. Therefore, our new research article in the SIC project focuses on the use of peptide bioregulators (such as Pielotax, Ovagen, and Renefort) in the prevention and treatment of kidney pathologies.
We are pleased to invite you to explore a new article from the Scientific Information Center on male health and peptide bioregulators — Application of peptide bioregulators to maintain the function of the male reproductive system.
In a recently conducted scientific study within the framework of the SIC project «Clinical and experimental studies of the efficacy of vascular peptides», an in-depth review of the primary aspects of the aforementioned topic will be conducted. The aspects addressed include:
